APGE · Categories · Downgrades

APGE - Analyst downgrades

Apogee Therapeutics Inc. (APGE) analyst downgrades - real-time wire coverage filtered to Downgrades only.

Recent Downgrades for APGE

• 224d
  Apogee Therapeutics downgraded by RBC Capital Mkts with a new price target

  RBC Capital Mkts downgraded Apogee Therapeutics from Outperform to Sector Perform and set a new price target of $83.00

Other APGE categories

• 8-K
• 10-K
• 10-Q
• S-1
• 13D
• 13G
• Form 4
• Form 3
• Form 5
• DEF 14A
• M&A
• Earnings